Zai Lab On Portfolio Strategy In Post Coronavirus China

Adapting To Changing Oncology Market

 
• By Brian Yang

Portfolio management is high on innovative drug maker’s mind amid aftermath of coronavirus outbreak.

Shanghai overpass
SHANGHAI'S ZAI LAB EXPANDS PORTFOLIO TO COMPETE IN POST-CORONAVIRUS CHINA • Source: Shutterstock

More from China

More from Focus On Asia